These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710 [TBL] [Abstract][Full Text] [Related]
4. Nicotinic acetylcholine involvement in cognitive function in animals. Levin ED; Simon BB Psychopharmacology (Berl); 1998 Aug; 138(3-4):217-30. PubMed ID: 9725745 [TBL] [Abstract][Full Text] [Related]
5. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Newhouse PA; Potter A; Levin ED Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280 [TBL] [Abstract][Full Text] [Related]
6. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking. Ochoa EL; Lasalde-Dominicci J Cell Mol Neurobiol; 2007 Aug; 27(5):609-39. PubMed ID: 17554626 [TBL] [Abstract][Full Text] [Related]
7. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia. McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711 [TBL] [Abstract][Full Text] [Related]
8. Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery. Terry AV; Callahan PM Nicotine Tob Res; 2019 Feb; 21(3):383-394. PubMed ID: 30137518 [TBL] [Abstract][Full Text] [Related]
9. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Martin LF; Freedman R Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863 [TBL] [Abstract][Full Text] [Related]
10. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders. Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665 [TBL] [Abstract][Full Text] [Related]
18. Nicotinic systems and cognitive function. Levin ED Psychopharmacology (Berl); 1992; 108(4):417-31. PubMed ID: 1357713 [TBL] [Abstract][Full Text] [Related]
19. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications. Toledano A; Alvarez MI; Toledano-Díaz A Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766 [TBL] [Abstract][Full Text] [Related]
20. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice. Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]